Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

被引:80
|
作者
Dugan, Haley L. [1 ]
Stamper, Christopher T. [1 ]
Li, Lei [2 ]
Changrob, Siriruk [2 ]
Asby, Nicholas W. [3 ]
Halfmann, Peter J. [4 ]
Zheng, Nai-Ying [2 ]
Huang, Min [2 ]
Shaw, Dustin G. [1 ]
Cobb, Mari S. [5 ]
Erickson, Steven A. [2 ]
Guthmiller, Jenna J. [2 ]
Stovicek, Olivia [2 ]
Wang, Jiaolong [2 ]
Winkler, Emma S. [6 ,7 ]
Madariaga, Maria Lucia [9 ]
Shanmugarajah, Kumaran [9 ]
Jansen, Maud O. [10 ]
Amanat, Fatima [11 ]
Stewart, Isabelle [2 ,16 ]
Utset, Henry A. [2 ]
Huang, Jun [1 ,3 ]
Nelson, Christopher A. [6 ]
Dai, Ya-Nan [6 ]
Hall, Paige D. [6 ]
Jedrzejczak, Robert P. [12 ,13 ]
Joachimiak, Andrzej [12 ,13 ,14 ]
Krammer, Florian [11 ]
Diamond, Michael S. [6 ,7 ,8 ]
Fremont, Daved H. [6 ]
Kawaoka, Yoshihiro [4 ,15 ]
Wilson, Patrick C. [1 ,2 ]
机构
[1] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA
[2] Univ Chicago, Sect Rheumatol, Dept Med, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA
[4] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Influenza Res Inst, Madison, WI 53711 USA
[5] Univ Chicago, Sect Genet Med, Chicago, IL 60637 USA
[6] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA
[7] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA
[8] Washington Univ, Dept Mol Immunol, Sch Med, St Louis, MO 63130 USA
[9] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
[10] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[11] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
[12] Univ Chicago, Ctr Struct Genom Infect Dis, Consortium Adv Sci & Engn, Chicago, IL 60439 USA
[13] Argonne Natl Lab, Struct Biol Ctr, Xray Sci Div, Lemont, IL 60439 USA
[14] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA
[15] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan
[16] Victoria Univ Wellington, Sch Biol Sci, Wellington 6012, New Zealand
基金
美国国家卫生研究院;
关键词
GERMINAL CENTER; MARGINAL ZONE; MEMORY; ACTIVATION; EXPRESSION; IDENTIFICATION; PROLIFERATION; MATURATION; SIGNATURES; SURVIVAL;
D O I
10.1016/j.immuni.2021.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for understanding antibody recallupon secondary exposure. Here, we usedsingle-cell sequencing to profile SARS-CoV-2-reactive B cells in 38 COVID-19 patients. Using oligo-tagged antigen baits, we isolated B cells specific to the SARS-CoV-2 spike, nucleoprotein (NP), open reading frame 8 (ORF8), and endemic human coronavirus (HCoV) spike proteins. SARS-CoV-2 spike-specific cells were enriched in the memory compartment of acutely infected and convalescent patients several months post symptom onset. With severe acute infection, substantial populations of endemic HCoV-reactive antibody-secreting cells were identified and possessed highlymutated variable genes, signifying preexisting immunity. Finally, MBCs exhibited pronounced maturation to NP and ORF8 over time, especially in older patients. Monoclonal antibodies against these targets were non-neutralizing and non-protective in vivo. These findings reveal antibody adaptation to non-neutralizing intracellular antigens during infection, emphasizing the importance of vaccination for inducing neutralizing spike-specific MBCs.
引用
收藏
页码:1290 / +
页数:21
相关论文
共 50 条
  • [21] A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
    Shi, Rui
    Shan, Chao
    Duan, Xiaomin
    Chen, Zhihai
    Liu, Peipei
    Song, Jinwen
    Song, Tao
    Bi, Xiaoshan
    Han, Chao
    Wu, Lianao
    Gao, Ge
    Hu, Xue
    Zhang, Yanan
    Tong, Zhou
    Huang, Weijin
    Liu, William Jun
    Wu, Guizhen
    Zhang, Bo
    Wang, Lan
    Qi, Jianxun
    Feng, Hui
    Wang, Fu-Sheng
    Wang, Qihui
    Gao, George Fu
    Yuan, Zhiming
    Yan, Jinghua
    NATURE, 2020, 584 (7819) : 120 - +
  • [22] Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
    Armel Landry Batchi-Bouyou
    Jean Claude Djontu
    Jeannhey Christevy Vouvoungui
    Claujens Chastel Mfoutou Mapanguy
    Line Lobaloba Ingoba
    Jiré Séphora Mougany
    Kamal Rauchelvy Boumpoutou
    Steve Diafouka-kietela
    Raoul Ampa
    Francine Ntoumi
    BMC Infectious Diseases, 22
  • [23] Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination
    Urlaub, Doris
    Wolfsdorff, Natalie
    Hoffmann, Jan-Erik
    Dorok, Stefanie
    Hoffmann, Markus
    Anft, Moritz
    Pieris, Naomi
    Guenther, Patrick
    Schaaf, Bernhard
    Cassens, Uwe
    Broede, Peter
    Claus, Maren
    Picard, Lea K.
    Wingert, Sabine
    Backes, Simone
    Durak, Deniz
    Babel, Nina
    Poehlmann, Stefan
    Renken, Frank
    Raunser, Stefan
    Watzl, Carsten
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (05) : 810 - 815
  • [24] Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
    Huang, Yen-Fang
    Hsu, Fang-Chi
    Wu, Jiunn-Jong
    Lin, Yi-Ling
    Liu, Ming-Tsan
    Yang, Chin-Hui
    Kuo, Hsu-Sung
    Chen, Yen-Ju
    Cheng, Chien-Yu
    Lin, His-Hsun
    Liao, Chun-Che
    Chang, Chih-Shin
    Liang, Jian-Jong
    Cheng, Wen-Yueh
    Huang, Jason C.
    Chen, Cheng-Pin
    Cheng, Shu-Hsing
    Lin, Yi-Chun
    Yang, Shung-Haur
    Chou, Yiing-Jenq
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (03) : 506 - 515
  • [25] Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
    Batchi-Bouyou, Armel Landry
    Djontu, Jean Claude
    Vouvoungui, Jeannhey Christevy
    Mfoutou Mapanguy, Claujens Chastel
    Lobaloba Ingoba, Line
    Mougany, Jire Sephora
    Boumpoutou, Kamal Rauchelvy
    Diafouka-kietela, Steve
    Ampa, Raoul
    Ntoumi, Francine
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [26] Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
    Dapporto, Francesca
    Marchi, Serena
    Leonardi, Margherita
    Piu, Pietro
    Lovreglio, Piero
    Decaro, Nicola
    Buonvino, Nicola
    Stufano, Angela
    Lorusso, Eleonora
    Bombardieri, Emilio
    Ruello, Antonella
    Viviani, Simonetta
    Molesti, Eleonora
    Trombetta, Claudia Maria
    Manenti, Alessandro
    Montomoli, Emanuele
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [27] Prolonged evolution of the human B cell response to SARS-CoV-2 infection
    Sakharkar, Mrunal
    Rappazzo, C. Garrett
    Wieland-Alter, Wendy F.
    Hsieh, Ching-Lin
    Wrapp, Daniel
    Esterman, Emma S.
    Kaku, Chengzi, I
    Wec, Anna Z.
    Geoghegan, James C.
    McLellan, Jason S.
    Connor, Ruth, I
    Wright, Peter F.
    Walker, Laura M.
    SCIENCE IMMUNOLOGY, 2021, 6 (56)
  • [28] B cell persistence and evolution to SARS-CoV-2
    Alrubayyi A.
    Nature Reviews Immunology, 2021, 21 (1) : 3 - 3
  • [29] Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
    Roltgen, Katharina
    Boyd, Scott D.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2024, 19 : 69 - 97
  • [30] Evolution of the SARS-CoV-2 specific B cell and antibody repertoires over time
    van der Bolt, Nieke
    Chernigovskaya, Maria
    Claireaux, Mathieu
    Visser, Remco
    van Alphen, Floris
    van der Burg, Mirjam
    ten Brinke, Anja
    Greiff, Victor
    Gils, Marit
    van der Schoot, Ellen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 48 - 48